Johnson & Johnson on Tuesday reported third-quarter earnings and revenue that beat expectations, boosted by higher sales of cancer and other prescription drugs, despite multimillion-dollar legal problems from talc and opioids. Here’s what the company reported compared with Wall Street estimates, based on a survey of analysts by Refinitiv: Adjusted earnings per share: $ 2.12… Read More »
Doctors are A THIRD more likely to prescribe opioids later in the day, study finds Physician fatigue and schedule may effect their decision-making Opioid over-prescribing is blamed in part for the current US opioid epidemic University of Minnesota researchers found that 4% of patients with early appointments get opioid prescriptions By the end of the… Read More »
The State of Maryland is getting new software to collect information about controlled substances dispensed in the state to facilitate better data sharing. The RxGov prescription drug monitoring platform, from NIC, provides near real-time data that will integrate with the Chesapeake Regional Information System for our Patients (CRISP), the state health information exchange. Data also… Read More »
People who inject drugs are at a high risk for a number of health issues. In a new study from ICES, Lawson Health Research Institute and Western University, researchers discovered a significant rise in the risk of infective endocarditis, a serious heart infection, among Ontarians who inject drugs. When examining opioid prescriptions in the province, the research team discovered… Read More »
The National Institutes of Health is making new investments into the BRAIN Initiative, which will include new studies of opioids. New funds of $ 220 million to support 200 new research awards have been awarded, bringing total 2018 program support to more than $ 400 million, which is 50 percent more than the amount spent… Read More »